Regulation of the Pharmaceutical-Biotechnology Industry
This chapter is a preliminary draft unless otherwise noted. It may not have been subjected to the formal review process of the NBER. This page will be updated as the chapter is revised.
Chapter in forthcoming NBER book Economic Regulation and Its Reform: What Have We Learned?, Nancy L. Rose, editor
This paper was revised on January 16, 2013